Rafael López López

Nasasbiotech is a Spanish biotechnology company focused on the development of innovative solutions for the diagnosis and treatment of cancer, particularly through the study of exosomes and liquid biopsy. Founded by Dr. Rafael López López, a leading oncologist, the company leverages its expertise in translational oncology to develop medical devices for capturing circulating tumor cells and therapeutic antibodies targeting metastatic pathways. Their lead programs include the Exo-Dict device for exosome isolation and a pipeline of monoclonal antibodies designed to inhibit tumor progression in high-unmet-need indications like glioblastoma. Nasasbiotech aims to transform cancer management by providing tools for earlier detection and more effective, personalized therapeutic interventions.